SCHEMBL5407521

SCHEMBL5407521

CNc1ccn2c(C(=O)c3ccc(N)c(OC)c3)c(C)[c]c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TUBB4A P04350 3/20 0.36
▸ TUBB P07437 3/20 0.36
▸ TUBA3C P0DPH7 3/20 0.36
▸ TUBA1B P68363 3/20 0.36
▸ TUBA4A P68366 3/20 0.36
▸ TUBB4B P68371 3/20 0.36
▸ TUBB3 Q13509 3/20 0.36
▸ TUBB2A Q13885 3/20 0.36
▸ TUBB8 Q3ZCM7 3/20 0.36
▸ TUBA3E Q6PEY2 3/20 0.36
▸ TUBA1A Q71U36 3/20 0.36
▸ TUBA1C Q9BQE3 3/20 0.36
▸ TUBB6 Q9BUF5 3/20 0.36
▸ TUBB2B Q9BVA1 3/20 0.36
▸ TUBB1 Q9H4B7 3/20 0.36
▸ SLC22A6 Q4U2R8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382277 0.84 ALDH1A1 (0.42) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL3947293 0.78 ALDH1A1 (0.36) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL5396416 0.78 ALDH1A1 (0.41) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL5782533 0.78 ALDH1A1 (0.40) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL5749185 0.71 L3MBTL1 (0.41) L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL436813 0.69 ALDH1A1 (0.72) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL6218407 0.69 MAPT (0.60) ALDH1A1LMNAHTTL3MBTL1CYP1A2
SCHEMBL1572805 0.68 MAPT (0.47) ALDH1A1LMNAHTTL3MBTL1MEN1
SCHEMBL3947795 0.68 POLB (0.38) ALDH1A1LMNAHTTL3MBTL1TUBB4A
SCHEMBL8622568 0.68 ALDH1A1 (0.70) ALDH1A1LMNAHTTL3MBTL1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007505867-A — — 2007-03-15 — — JP claimed
EP-1664047-A1 SUBSTITUTED INDOLIZINE 1,2,3,6,7,8 DERIVATIVES, FGFS INHIBITORS, A METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES Sanofi-Aventis (FR) 2006-06-07 — — EP claimed
WO-2005028476-A1 SUBSTITUTED INDOLIZINE 1,2,3,6,7,8 DERIVATIVES, FGFS INHIBITORS, A METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES SANOFI-AVENTIS (FR) 2005-03-31 — — WO claimed
EP-1664047-A1 SUBSTITUTED INDOLIZINE 1,2,3,6,7,8 DERIVATIVES, FGFS INHIBITORS, A METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES Sanofi-Aventis (FR) 2006-06-07 — — EP disclosed
WO-2005028476-A1 SUBSTITUTED INDOLIZINE 1,2,3,6,7,8 DERIVATIVES, FGFS INHIBITORS, A METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES SANOFI-AVENTIS (FR) 2005-03-31 — — WO disclosed
Send feedback